Primary Dysmenorrhea
Conditions
Brief summary
Proportion of patients who respond to treatment defined as: a) a ≥3-point reduction in the peak pelvic pain score assessed in the cramping window of Cycle 5 compared to Baseline AND b) no increase in the number of standard pain relief medication taken in the cramping window of Cycle 5 compared to Baseline.
Interventions
DRUGPlacebo
DRUGDRY EXTRACT FROM CHASTE TREE FRUITS (7-11:1)
DRUGEXTRACTION SOLVENT: ETHANOL 70% (V/V)
Sponsors
Bionorica SE
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients who respond to treatment defined as: a) a ≥3-point reduction in the peak pelvic pain score assessed in the cramping window of Cycle 5 compared to Baseline AND b) no increase in the number of standard pain relief medication taken in the cramping window of Cycle 5 compared to Baseline. | — |
Countries
Austria, Czechia, Germany, Hungary, Poland, Sweden
Outcome results
None listed